Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
415 studies found for:    E3A06
Show Display Options
Rank Status Study
1 Recruiting Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Conditions: Light Chain Deposition Disease;   Smoldering Plasma Cell Myeloma
Interventions: Drug: Lenalidomide;   Other: Clinical Observation;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
2 Completed
Has Results
Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment
Condition: Post-Traumatic Stress Disorder
Interventions: Behavioral: CAPS/WHODAS;   Behavioral: Nonstructured Interview
3 Completed A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: ONO-4641;   Drug: ONO-4641 placebo
4 Completed A Pharmacokinetic Evaluation of Bioidentical Compounded Estrogen Cream and Natural Progesterone
Condition: Menopause
Interventions: Drug: bioidentical hormone (Biest);   Drug: bioidentical hormone (Vivelle-Dot)
5 Terminated
Has Results
Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Disease
Interventions: Drug: Aliskiren;   Drug: Placebo
6 Completed
Has Results
Special Investigation (Follow up Survey of the Study of Adalimumab (D2E7)for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859(NCT00870467)
Condition: Rheumatoid Arthritis
Intervention:
7 Completed A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome
Condition: Coronary Heart Disease
Interventions: Drug: dalcetrapib;   Drug: Placebo;   Drug: Evidence-based medical care for Acute Coronary Syndrome
8 Enrolling by invitation Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Conditions: Muscular Dystrophy, Duchenne;   Muscular Dystrophies;   Muscular Disorders, Atrophic;   Muscular Diseases;   Musculoskeletal Diseases;   Neuromuscular Diseases;   Nervous System Diseases;   Genetic Diseases, X-Linked;   Genetic Diseases, Inborn
Intervention: Drug: Ataluren
9 Completed The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Condition: Acute Coronary Syndrome
Interventions: Drug: Darapladib 160 mg;   Drug: Placebo;   Other: Standard Therapy
10 Completed
Has Results
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: motavizumab (MEDI-524);   Biological: palivizumab
11 Completed
Has Results
Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
Conditions: Diabetes, Type 1;   Diabetes, Type 2
Interventions: Drug: Technosphere® Insulin Inhalation Powder;   Drug: Usual Care
12 Active, not recruiting Phase 3 Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy
Conditions: Muscular Dystrophy, Duchenne;   Muscular Dystrophies;   Muscular Disorders, Atrophic;   Muscular Diseases;   Musculoskeletal Diseases;   Neuromuscular Diseases;   Nervous System Diseases;   Genetic Diseases, X-Linked;   Genetic Diseases, Inborn
Interventions: Drug: Ataluren;   Drug: Placebo
13 Completed A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
Condition: Cardiovascular Disease, Diabetes Mellitus, Type 2
Interventions: Drug: Placebo;   Drug: aleglitazar
14 Completed A Study in Patients With Type I Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Glargine;   Drug: LY2605541;   Drug: Insulin Lispro
15 Recruiting Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: BAF312;   Drug: Placebo
16 Unknown  Study of DNA Samples From Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Intervention: Genetic: polymorphism analysis
17 Completed
Has Results
Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: olanzapine;   Drug: olanzapine pamoate depot
18 Completed
Has Results
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Conditions: Angina Pectoris;   Coronary Artery Disease;   Type 2 Diabetes Mellitus
Interventions: Drug: Ranolazine;   Drug: Ranolazine placebo
19 Completed Vitamin D Dose-Response Study to Establish Dietary Requirements in Infants
Condition: Vitamin D Deficiency
Intervention: Drug: Vitamin D
20 Active, not recruiting Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
Condition: Crohn's Disease
Intervention: Biological: Adalimumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years